Exalenz Bioscience Receives FDA Marketing Clearance for its Laboratory System in the United States
November 01, 2016 at 08:02 am
Exalenz Bioscience announced receiving U.S. Food and Drug Administration marketing clearance for its BreathID® Lab System and breath-test kits, developed for H. pylori bacterium detection. The company is preparing to penetrate the laboratory market in the United States by engaging with national and regional laboratories, to achieve a broad and material presence in a market with a potential that is estimated at hundreds of millions of dollars in sales per year.